135 related articles for article (PubMed ID: 27735911)
1. [Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis].
Afanasievа OI; Pylaeva EA; Klesareva EA; Potekhina AV; Provatorov SI; Afanasieva MI; Krasnikova TL; Masenko VP; Arefieva TI; Pokrovsky SN
Ter Arkh; 2016; 88(9):31-38. PubMed ID: 27735911
[TBL] [Abstract][Full Text] [Related]
2. [Effector and regulatory blood lymphocyte subpopulations in stable coronary artery disease].
Pylaeva EA; Potekhina AV; Provatorov SI; Raskina KV; Ruleva NIu; Masenko VP; Noeva EA; Krasnikova TL; Aref'eva TI
Ter Arkh; 2014; 86(9):24-30. PubMed ID: 25518502
[TBL] [Abstract][Full Text] [Related]
3. [Autoantibodies against lipoprotein(a) in patients with coronary heart disease].
Afanas'eva OI; Klesareva EA; Levashev PA; Berestetskaia IuV; Ezhov MV; Artem'eva NV; Pokrovskiĭ SN
Kardiologiia; 2014; 54(6):4-8. PubMed ID: 25178070
[TBL] [Abstract][Full Text] [Related]
4. [Elevated Lipoprotein(a) Cncentration and Presence of Subfractions of Small Dense Low Density Lipoproteins as Independent Factors of Risk of Ischemic Heart Disease].
Afanasieva OI; Utkina EA; Artemieva NV; Ezhov MV; Adamova IY; Pokrovsky SN
Kardiologiia; 2016 Jun; 56(6):5-11. PubMed ID: 28290840
[TBL] [Abstract][Full Text] [Related]
5. Treg/Th17 balance in stable CAD patients with different stages of coronary atherosclerosis.
Potekhina AV; Pylaeva E; Provatorov S; Ruleva N; Masenko V; Noeva E; Krasnikova T; Arefieva T
Atherosclerosis; 2015 Jan; 238(1):17-21. PubMed ID: 25461734
[TBL] [Abstract][Full Text] [Related]
6. Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a).
Krychtiuk KA; Kastl SP; Hofbauer SL; Wonnerth A; Goliasch G; Ozsvar-Kozma M; Katsaros KM; Maurer G; Huber K; Dostal E; Binder CJ; Pfaffenberger S; Oravec S; Wojta J; Speidl WS
J Clin Lipidol; 2015; 9(4):533-41. PubMed ID: 26228671
[TBL] [Abstract][Full Text] [Related]
7. [The Relationship of the Concentration of Lipoprotein(a) and Markers of Inflammation with Multifocal Atherosclerosis in Women].
Afanasieva OI; Tmoyan NA; Klesareva EA; Razova OA; Ezhov MV; Afanasieva MI; Pokrovsky SN
Kardiologiia; 2019 Oct; 59(10):39-48. PubMed ID: 31615387
[TBL] [Abstract][Full Text] [Related]
8. Low Blood Content of IL-10-Producing CD4
Filatova AY; Pylaeva EA; Potekhina AV; Ruleva NY; Klesareva EA; Radyukhina NV; Masenko VP; Shchinova AM; Noeva EA; Provatorov SI; Afanas'eva OI; Aref'eva TI
Bull Exp Biol Med; 2019 Jan; 166(3):330-333. PubMed ID: 30627915
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Lipoprotein(a)-Containing Circulating Immune Complexes as Markers of Coronary Heart Disease.
Klesareva EA; Afanas'eva OI; Donskikh VV; Adamova IY; Pokrovskii SN
Bull Exp Biol Med; 2016 Dec; 162(2):231-236. PubMed ID: 27905032
[TBL] [Abstract][Full Text] [Related]
10. Heritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.
Rao F; Schork AJ; Maihofer AX; Nievergelt CM; Marcovina SM; Miller ER; Witztum JL; O'Connor DT; Tsimikas S
Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1704-11. PubMed ID: 25953646
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
[TBL] [Abstract][Full Text] [Related]
12. Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: using different capture antibody against oxidized lipoprotein (a) or oxidized LDL.
Wang JJ; Han AZ; Meng Y; Gong JB; Zhang CN; Li K; Liu YX
Clin Biochem; 2010 Apr; 43(6):571-5. PubMed ID: 20060390
[TBL] [Abstract][Full Text] [Related]
13. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
Rasouli M; Kiasari AM; Mokhberi V
Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
[TBL] [Abstract][Full Text] [Related]
14. Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease.
Rasouli M; Kiasari AM
Clin Chem Lab Med; 2008; 46(5):667-73. PubMed ID: 18598204
[TBL] [Abstract][Full Text] [Related]
15. TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease.
Szodoray P; Timar O; Veres K; Der H; Szomjak E; Lakos G; Aleksza M; Nakken B; Szegedi G; Soltesz P
Scand J Immunol; 2006 Sep; 64(3):336-44. PubMed ID: 16918703
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Filatova AY; Vitsenya MV; Potekhina AV; Gavryushina SV; Pylaeva EA; Pestova AB; Stenina MB; Frolova MA; Shchinova AM; Klesareva EA; Afanasieva OI; Arefeva TI; Ageev FT
Kardiologiia; 2019 Jan; 59(1S):43-52. PubMed ID: 30706838
[TBL] [Abstract][Full Text] [Related]
17. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
[TBL] [Abstract][Full Text] [Related]
18. The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization.
Fefer P; Tsimikas S; Segev A; Sparkes J; Otsuka F; Kolodgie F; Virmani R; Juliano J; Charron T; Strauss BH
Cardiovasc Revasc Med; 2012; 13(1):11-9. PubMed ID: 22079685
[TBL] [Abstract][Full Text] [Related]
19. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.
Bossola M; Tazza L; Luciani G; Tortorelli A; Tsimikas S
J Nephrol; 2011; 24(5):581-8. PubMed ID: 21404224
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) is an important factor to determine coronary artery plaque morphology in patients with acute myocardial infarction.
Hikita H; Shigeta T; Kojima K; Oosaka Y; Hishikari K; Kawaguchi N; Nakashima E; Sugiyama T; Akiyama D; Kamiishi T; Kimura S; Takahashi Y; Kuwahara T; Sato A; Takahashi A; Isobe M
Coron Artery Dis; 2013 Aug; 24(5):381-5. PubMed ID: 23652366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
